PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-32.44%
Negative 5Y CAGR while VMC stands at 48.36%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-44.51%
Negative 3Y CAGR while VMC stands at 28.18%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
486.80%
5Y OCF/share CAGR at 50-75% of VMC's 657.52%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
2310.96%
3Y OCF/share CAGR above 1.5x VMC's 461.25%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
No Data
No Data available this quarter, please select a different quarter.
354.02%
5Y net income/share CAGR similar to VMC's 337.67%. Walter Schloss might see both on parallel mid-term trajectories.
-35.62%
Negative 3Y CAGR while VMC is 74.54%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
51.34%
5Y equity/share CAGR 1.25-1.5x VMC's 36.93%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
46.80%
3Y equity/share CAGR above 1.5x VMC's 25.12%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
135.88%
5Y dividend/share CAGR at 50-75% of VMC's 240.07%. Martin Whitman might see a lagging policy in mid-term shareholder returns.
55.15%
3Y dividend/share CAGR above 1.5x VMC's 36.13%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.